Skip to content

Sana Biotechnology SANA Cash Received For Tenant Improvement Allowances

Cash Received For Tenant Improvement Allowances at other companies

LiveRamp Holdings, Inc. logo
LiveRamp Holdings, Inc.RAMP
$0+100%
Vestis logo
VestisVSTS
$25K-97.8%
Kimbell Royalty Partners logo
Kimbell Royalty PartnersKRP
$0-100%
Evercore logo
EvercoreEVR
$16.56M-4.3%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$5.8M
GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$8.98M+3.1%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$912.8M+54.1%
Enterprise value$904.32M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept sana:CashReceivedForTenantImprovementAllowances.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's cash received for tenant improvement allowances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's cash received for tenant improvement allowances?
Sana Biotechnology (SANA) reported cash received for tenant improvement allowances of $0 in Q1 2026.
How has Sana Biotechnology's cash received for tenant improvement allowances changed year-over-year?
Sana Biotechnology's cash received for tenant improvement allowances decreased by 100.0% year-over-year, from $891K to $0.
What is the long-term trend for Sana Biotechnology's cash received for tenant improvement allowances?
Over 2 years (2021 to 2024), Sana Biotechnology's cash received for tenant improvement allowances has grown at a 17.4% compound annual growth rate (CAGR), from $5.45M to $7.51M.
What does cash received for tenant improvement allowances mean?
This metric tracks the cash inflows received from landlords as allowances to offset the costs of building out or improving leased laboratory and office spaces. It represents a form of financing or cost recovery that reduces the net capital expenditure burden for facility development. It is a useful indicator of the company's ability to negotiate favorable lease terms that subsidize infrastructure investment.